Semaglutide is a long-acting, selective, competitive glucagon-like peptide-1 receptor (GLP-1R) agonist that can cross the blood-brain barrier. By activating GLP-1R signaling, semaglutide stimulates glucose-dependent insulin secretion, delays gastric emptying, and suppresses appetite. In addition, semaglutide modulates several cellular pathways, including enhancing autophagy, reducing oxidative stress and apoptosis, and regulating mitochondrial function and lipid metabolism. Semaglutide exhibits a range of pharmacological activities, including glucose-lowering, weight-reducing, neuroprotective, and hepatoprotective effects. It is widely studied in the context of metabolic and neurological disorders, including type 2 diabetes, obesity, Parkinson's disease, metabolic dysfunction-associated steatotic liver disease (MASLD), and cance. Semaglutide may therefore serve as a useful research tool for investigating GLP-1R signaling, metabolism, neurodegeneration, liver disease, and related cellular mechanisms. Reagent grade. For research use only, not for human use.
Usually ships within 24 hours.